临床分析复发性尿路感染患者的细菌检验与药敏情况

A clinical analysis of bacterial test and drug sensitivity in recurrent urinary tract infection

目的:研究复发性尿路感染患者的细菌检验与药敏情况,并分析其治疗的应对策略。方法:选取我院2013年6月-2014年6月期间接受治疗的88例复发性尿路感染患者,经检验均属于尿细菌以及药敏感,将患者分为培养阳性与阴性两组进行治疗研究,并记录治疗的结果,对比两组患者的临床检验结果。结果:88例患者中有33例呈尿细菌培养阳性,大肠埃希菌26例。经治疗,治愈率为79/88,治愈患者中27例为细菌培养阳性组患者,52例为阴性组患者。经对比,数据结果无显著统计学差异,P>0.05。经590次药敏试验后,临床表现出敏感60次,10.17%的敏感率。结论:在复发性尿路感染患者临床检验中,研究其长期的接诊治疗,对于分期治疗的方法以及药敏试验效果,应根据临床药敏症状进行抗生素选择,避免在接受治疗期间产生不良反应,影响治疗。

Objective: To study the bacterial testing and drug susceptibility of patients with recurrent urinary tract infection. Methods:88 patients with recurrent urinary tract infection were divided into two groups: the culture positive and negative groups. Results: In 88 patients, 33 patients were positive for urinary bacterial culture; 26 patients were for escherichia coli. The healing rate was 79/88. Among the cured patients, 27 patients were positive for bacterial culture; 52 patients were negative. After 590 times of susceptibility test, the clinical manifestation sensitivity were 60 times, account for 10.17%. Conclusion: Patients with recurrent urinary tract infection should choose antibiotics according to the clinical drug susceptibility symptoms to avoid the long-term treatment for recurrent urinary tract infection.